Clinical Trials Directory

Trials / Terminated

TerminatedNCT02597153

Phase II Clinical Study of PLM60 for the Treatment of Cutaneous T Cell Lymphomas

A Single-arm, Open, Multi-center Phase II Clinical Trial of Mitoxantrone HCL Liposome Injection in Subjects With Relapsed Cutaneous T Cell Lymphomas

Status
Terminated
Phase
Phase 2
Study type
Interventional
Enrollment
1 (actual)
Sponsor
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · Industry
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

To study efficacy and safety of Mitoxantrone HCL Liposome Injection in patients with relapsed cutaneous T cell lymphomasell

Conditions

Interventions

TypeNameDescription
DRUGMitoxantrone HCL Liposome Injection

Timeline

Start date
2015-10-01
Primary completion
2017-10-01
Completion
2020-10-01
First posted
2015-11-05
Last updated
2017-05-24

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02597153. Inclusion in this directory is not an endorsement.